Key result
DOACs require careful geriatric management to navigate falls, cognitive impairment, swallowing disorders, and polypharmacy.
Why the study?
An aging global population with increasing cardiovascular diseases has led to a large number of geriatric patients requiring oral anticoagulation, presenting challenges in managing DOACs alongside geriatric syndromes.
Answers are grounded in this paper and cite their sources.
This review provides practical guidance on managing DOAC therapy in geriatric patients with complex syndromes such as cognitive impairment, fall risk, and polypharmacy.
Because the number of elderly people is increasing worldwide, and the prevalence of cardiovascular risk factors and cardiovascular diseases increase with age, in current clinical practice we are faced with a large number of geriatric patients requiring oral anticoagulant treatment. Our review highlights some of the particularities of using direct oral anticoagulants (DOACs) in the geriatric population. We focused on the difficulties of managing DOAC treatment in the presence of geriatric syndromes. We highlighted the practical steps needed to overcome the challenges related to the risk of falling, cognitive impairment, swallowing disorders, and polypragmasy to improve patient care. We provided data to help guide the choice of anticoagulant and dose.
No takes yet. Share an insight, caveat, or question.
Bădescu et al. (2025) conducted a review in Geriatric patients requiring oral anticoagulant treatment. Direct Oral Anticoagulants (DOACs) was evaluated. Direct oral anticoagulants (DOACs) require careful management in geriatric patients to overcome challenges related to falls, cognitive impairment, swallowing disorders, and polypharmacy.
Synapse has enriched 10 related papers. Consider them for comparative context: